Latest Breaking News On - Terry horner chair - Page 3 : comparemela.com

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2023 Pliant Therapeutics, Inc. today announced it will host a conference call and webcast on Tuesday, September 26, 2023 at 8:00 a.m. ET | 5:00 a.m. PT to.

Gideon hirschfieldChristopher keenanTerry hornerPliant therapeutics incDrug administrationCorporate communicationsEuropean medicines agencyUniversity of torontoTerry horner chairAutoimmune liver diseasePliant therapeuticsFast track designationOrphan drug designationMedia contactInvestor relations

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Christopher keenanGideon hirschfieldTerry hornerPliant therapeutics incDrug administrationEuropean medicines agencyUniversity of torontoCorporate communicationsPliant therapeuticsTerry horner chairAutoimmune liver diseaseFast track designationOrphan drug designationMedia contactInvestor relations

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Gideon hirschfieldChristopher keenanTerry hornerDrug administrationUniversity of torontoCorporate communicationsEuropean medicines agencyPliant therapeutics incHost investor callDiscuss interim resultsPrimary sclerosingTerry horner chairAutoimmune liver diseasePliant therapeuticsFast track designationOrphan drug designation

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis

Terry hornerGideon hirschfieldChristopher keenanDrug administrationPliant therapeutics incUniversity of torontoEuropean medicines agencyCorporate communicationsPliant therapeuticsTerry horner chairAutoimmune liver diseaseFast track designationOrphan drug designationMedia contactInvestor relations

Ask me about PBC campaign calls on patients to speak up for rare liver disease

Ask me about PBC campaign calls on patients to speak up for rare liver disease
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesTerry hornerBettinae hansenAndreas kremerJohn puisisGideon hirschfieldRobert stottBysara kellnerInternational primary biliary cholangitis dayIntercept pharmaceuticalsAmerican liver foundationUniversity of miami miller school medicineUniversity of torontoPrimary biliary cholangitis dayCymabay therapeuticsClinical gastroenterology